Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2017
At a glance
- Drugs Naltrexone/bupropion (Primary)
- Indications Binge-eating disorder; Obesity
- Focus Therapeutic Use
- 06 Feb 2017 Status changed from active, no longer recruiting to completed.
- 24 Jun 2016 Planned End Date changed from 1 Apr 2016 to 1 Dec 2016.
- 24 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Sep 2016.